A two-stage approach to genetic risk assessment in primary care.

about

A two-stage approach to genetic risk assessment in primary care.

Item

http://www.wikidata.org/entity/Q36547135

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A two-stage approach to genetic risk assessment in primary care.

@ast

A two-stage approach to genetic risk assessment in primary care.

@en

type

Item

label

A two-stage approach to genetic risk assessment in primary care.

@ast

A two-stage approach to genetic risk assessment in primary care.

@en

prefLabel

A two-stage approach to genetic risk assessment in primary care.

@ast

A two-stage approach to genetic risk assessment in primary care.

@en

P1476

A two-stage approach to genetic risk assessment in primary care.

@en

P2093

Amanda L Blackford

http://www.w3.org/2001/XMLSchema#string

Banu Arun

http://www.w3.org/2001/XMLSchema#string

Giovanni Parmigiani

http://www.w3.org/2001/XMLSchema#string

Jonathan Chipman

http://www.w3.org/2001/XMLSchema#string

Kevin Hughes

http://www.w3.org/2001/XMLSchema#string

Philamer Atienza

http://www.w3.org/2001/XMLSchema#string

Swati Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

BayesMendel: an R environment for Mendelian risk prediction

Incorporating medical interventions into carrier probability estimation for genetic counseling.

Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO.

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

PancPRO: risk assessment for individuals with a family history of pancreatic cancer.

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.

Validity of models for predicting BRCA1 and BRCA2 mutations

P2888

s10549-016-3686-2

P304

375-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-016-3686-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291341901

http://www.w3.org/2001/XMLSchema#string

P698

26786860

http://www.w3.org/2001/XMLSchema#string

P932

4742331

http://www.w3.org/2001/XMLSchema#string